Single-Cycle of BEP Shows Promise Against Testicular Cancer Recurrence

A single cycle of adjuvant bleomycin, etoposide, and cisplatin (BEP) chemotherapy might reduce recurrence rates for nonseminomatous or combined germ cell tumors of the testis.

Source: CancerNetwork - February 18, 2017 Category: Cancer & Oncology Authors: Bryant Furlow Tags: ASCO Genitourinary Cancers Symposium News Testicular Cancer Source Type: news